Search research articles
Contact Us
Filters
Showing results (1-10 of 54) with videos related to
Page
of 6
Sort By:
Evidence-Based Medicine
|
September 14, 2013
Multitreatment comparison meta-analysis: promise and peril
Denise Campbell-Scherer
Annals of Family Medicine
|
May 22, 2023
New Insights and Future Directions: The Importance of Considering Poverty in Studies of Obesity and Diabetes
Denise Campbell-Scherer
Evidence-Based Medicine
|
March 9, 2017
Semaglutide is non-inferior to placebo for cardiovascular outcomes in patients with type 2 diabetes
Denise Campbell-Scherer
BMJ Evidence-Based Medicine
|
June 21, 2019
Evidence from large Danish cohort does not support an association between the MMR vaccine and autism: facts in a post-truth world
Denise Campbell-Scherer
Evidence-Based Medicine
|
November 26, 2010
Multimorbidity: a challenge for evidence-based medicine
Denise Campbell-Scherer
Evidence-Based Medicine
|
March 10, 2017
Reflections on using non-inferiority randomised placebo controlled trials in assessing cardiovascular safety of new agents for treatment of type 2 diabetes
Denise Campbell-Scherer
Evidence-Based Medicine
|
June 28, 2012
The 11th hour--time for EBM to return to first principles?
Denise Campbell-Scherer
Evidence-Based Medicine
|
November 27, 2015
Improving reporting and utility of evaluations of complex interventions
Denise Campbell-Scherer, Richard Saitz
Current Obesity Reports
|
June 26, 2016
Improving Obesity Prevention and Management in Primary Care in Canada
Denise Campbell-Scherer, Arya Mitra Sharma
Canadian Family Physician Medecin De Famille Canadien
|
November 14, 2015
The skinny on BMI and mortality
Braiden Hellec, Denise Campbell-Scherer, G Michael Allan
Page
of 6
Search research articles
Search
Showing results (1-10 of 54) with videos related to
Sort By:
Page
of 6
Evidence-Based Medicine
|
September 14, 2013
Multitreatment comparison meta-analysis: promise and peril
Denise Campbell-Scherer
Annals of Family Medicine
|
May 22, 2023
New Insights and Future Directions: The Importance of Considering Poverty in Studies of Obesity and Diabetes
Denise Campbell-Scherer
Evidence-Based Medicine
|
March 9, 2017
Semaglutide is non-inferior to placebo for cardiovascular outcomes in patients with type 2 diabetes
Denise Campbell-Scherer
BMJ Evidence-Based Medicine
|
June 21, 2019
Evidence from large Danish cohort does not support an association between the MMR vaccine and autism: facts in a post-truth world
Denise Campbell-Scherer
Evidence-Based Medicine
|
November 26, 2010
Multimorbidity: a challenge for evidence-based medicine
Denise Campbell-Scherer
Evidence-Based Medicine
|
March 10, 2017
Reflections on using non-inferiority randomised placebo controlled trials in assessing cardiovascular safety of new agents for treatment of type 2 diabetes
Denise Campbell-Scherer
Evidence-Based Medicine
|
June 28, 2012
The 11th hour--time for EBM to return to first principles?
Denise Campbell-Scherer
Evidence-Based Medicine
|
November 27, 2015
Improving reporting and utility of evaluations of complex interventions
Denise Campbell-Scherer, Richard Saitz
Current Obesity Reports
|
June 26, 2016
Improving Obesity Prevention and Management in Primary Care in Canada
Denise Campbell-Scherer, Arya Mitra Sharma
Canadian Family Physician Medecin De Famille Canadien
|
November 14, 2015
The skinny on BMI and mortality
Braiden Hellec, Denise Campbell-Scherer, G Michael Allan
Page
of 6